Elyxium Wealth’s Integra LifeSciences IART Stock Holding History

Elyxium Wealth’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.86K	Buy	+360	New	+$6.22K	﹤0.01%	1138

Other funds holding IART

Access Investment Management Atlanta, Georgia $412M AUM 14.18% 1-Year Est. Return

Leeward Investments Boston, Massachusetts $1.98B AUM 28.98% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return

Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return

State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return

Choreo LLC Rockford, Illinois $9.7B AUM 18.43% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Elyxium Wealth's IART Position: Q3 2026 in Review

Elyxium Wealth opened a new position in Integra LifeSciences (IART) in Q3 2026: 360 shares worth $5.86K. The stake represents ﹤0.01% of the portfolio and ranks #1138 among its holdings.

40 funds tracked by Wall St. Rank hold IART as of Q3 2026.

Elyxium Wealth held 360 shares of Integra LifeSciences worth $5.86K as of Q3 2026.
Integra LifeSciences was a new Elyxium Wealth position in Q3 2026.
Integra LifeSciences made up ﹤0.01% of Elyxium Wealth's portfolio in Q3 2026, its #1138 holding.
40 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2026.

Based on Elyxium Wealth's 13F filing for Q3 2026, filed 27 Oct 2026.